Breast CancerTHRIVORS+BHNCT03651037
Physical Activity Platform to Improve Bone Health in Cancer Survivors
A study testing Thrivors+BH in people with Breast Cancer and Physical Activity, run by Thrivors Inc at 1 site in United States.
Trial summary
Cancer treatment-induced bone loss and the subsequent risk of fractures in both men and women impacts not just survivors' quality of life, but is also a significant burden on national health care. Read more about this study
- Who is it for?
- Ages 40 to 70 years, women only
- Conditions the study is for
- Breast Cancer, Physical Activity, Bone Health
- What is being tested?
- Thrivors+BH
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 134 participants
- Where
- 1 siteUnited States
- Study dates
- 21 Jan 2019to 1 Mar 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 70 years
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Female participants diagnosed at 40 - 70 years with non-metastatic breast cancer.
- Able to provide written informed consent.
- Completed chemotherapy, undergoing adjuvant hormonal therapy.
- Not currently on a prescribed exercise plan and cleared for exercise by physician.
- Access to a smart phone (with a data plan), tablet, or computer (with internet access).
- Able and willing to comply with the protocol, including completion of all surveys.
Who cannot join
- Less than 4 weeks post-surgery.
- Diagnosis of osteoporosis.
- Currently participating in two or more 30-min. sessions/week of resistance or impact exercises.
- Specific condition(s) or diagnosis, both physical or psychological, or physical exam finding that precludes participation in a physical exercise program.
- Participant has hemodynamically significant heart disease (e.g., heart failure) or an arrhythmic heart condition requiring medical therapy.
- Employees or family members of the investigator, study site, or sponsor directly involved with study management.
- Participants who, in the opinion of the primary investigator, should not participate in the study.
Trial locations and contacts
1 site in 1 country.
About this study
Cancer treatment-induced bone loss and the subsequent risk of fractures in both men and women impacts not just survivors' quality of life, but is also a significant burden on national health care. Clinical studies have reported that moderate-intensity resistance exercises prevent a decline in bone health in female cancer survivors, and that strength training may reduce complications associated with cancer such as fatigue, muscle wasting, and bone loss. Unfortunately, only a small percentage of women who have had cancer, engage in and adhere to a strength training exercise routine.
The investigators have developed an internet-based application, Thrivors, that guides cancer survivors through exercise routines with light-to-moderate strength training in the home setting, and connects them to survivorship resources. In this Phase I proposal, the investigators will develop and deploy an enhanced version, Thrivors+BH, that disseminates resistance training exercises specifically impacting bone health (BH), integrated with video-based interactive feedback and tracking of adherence to exercise routines.
The goal is to validate Thrivors+BH as a novel tool to bridge the gaps between cancer survivorship, physical activity, value-based care and health care organizations (providers and payers), to positively impact bone health in breast cancer survivors.
Read the detailed description
Significance: Cancer treatment-induced bone loss and the subsequent risk of fractures in both men and women is a significant burden on national health care. The number of cancer survivors in the United States will reach 18 million by 2022 and by 2025, the projected burden of osteoporosis is $25.3 billion. Cancer patients treated with medications that lower hormone levels face an increased risk of fractures. Clinical studies report that moderate- intensity resistance exercises prevent a decline in bone health in female cancer survivors, and that strength training may reduce complications associated with cancer such as fatigue, muscle wasting, and bone loss. Unfortunately, only a small percentage of female cancer survivors engage in and adhere to a strength training exercise routine. Several factors account for this low level of engagement such as poor awareness of the benefits of exercise, lack of motivation, and the lack of affordable and easily accessible exercise programs designed for cancer survivors. Internet-based self-managed programs of exercises and guidance can potentially address these problems, and can be scaled for broader dissemination.
Innovation: The Thrivors internet-based platform seeks to shift the current paradigm of poor adherence to exercise by providing an affordable and accessible means of improving outcomes for cancer survivors. The proposed product, Thrivors+BH, will be a first-of-its-kind offering of clinically validated bone health exercises that can be customized to a cancer survivor's pain and energy levels, with several novel interactive feedback features. The product will also have supportive modules for connecting with a community of other users, mindfulness training, nutritional advice and a repository of educational information. The Thrivors platform is scalable, device-agnostic, and allows analysis of de-identified usage data. With commercialization potential for healthcare providers and health insurance payers, Thrivors provides a value-based care delivery model focused on outcomes. There are multiple important physiologic and psychosocial secondary conditions that could be positively impacted by the Thrivors platform. For this specific application, the investigators will focus on adherence to bone health exercises.
Hypothesis: The investigators hypothesized that breast cancer survivors' adherence to an exercise regimen for bone health can be improved by enhancing the interactive and customizable features of a cloud-based, device-agnostic delivery method. To test the hypothesis and to establish the technical feasibility of the product, the investigators propose the following specific aims:
Specific Aim 1: Develop an enhanced participant experience platform for bone health-specific exercises.
For Thrivors+BH, a module will be developed for participants to input pain and energy levels, enabling real-time customization of exercise regimens. Modules of clinically validated bone health exercises with instructional videos will be developed. Additionally, participants will be able upload and send videos of themselves exercising for feedback and assessment. A Thrivors Basic version that lacks customization and video content will be developed. Both versions will contain bone health educational content, mindfulness and nutrition resources. Milestones: Over a 2-month period, development, usability testing (assessing content, features, input controls, navigational ease and click-through capabilities) and refinement will be completed, to enable deployment in a randomized clinical trial.
Specific Aim 2: Measure participant adherence and engagement. The two versions of the platform will be deployed in a 20-week, two-arm randomized controlled trial of 50 breast cancer survivors. Adherence to exercise sessions (primary outcome) and platform usage will be measured by platform software, while user engagement (secondary outcomes) will be assessed by surveys. Milestones: Differences between primary and secondary outcomes for the control and intervention groups will be evaluated. Usage statistics, motivational responses and user feedback will be used to further refine platform features and content.
The outcomes of this study will help validate the utility of the Thrivors platform in improving cancer survivors' adherence and engagement to exercise routines that positively impact post-treatment recovery. In the near-term, the findings will inform the design of a 12-month Phase II study to evaluate changes in biomarkers of bone health. In the longer term, the project aligns with the business goal to disseminate the Thrivors platform to a larger population of male and female cancer survivors across ethnic/racial minority groups, rural populations, and low socioeconomic status groups. The project also aligns with the mission of the NCI to develop innovative technology and service delivery models that increase the adoption, uptake, and sustainability of evidence-based interventions to improve public health.
- Conditions
- Breast Cancer, Physical Activity, Bone Health
- Being tested
- Thrivors+BH
- Keywords
- cancer, bone health, physical activity, technology platfrom
- Medical subject headings
- Breast Neoplasms, Motor Activity, Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Thrivors+BHBehavioural
Also called Thrivors
Digital health platform for breast cancer patients that measures adherence and engagement.
| Study group | Role | What they receive |
|---|---|---|
| Thrivors+BH | Experimental | For Thrivors+BH, a module will be developed for users to input pain and energy levels, enabling real-time customization of exercise regimens. Modules of clinically validated bone health exercises with instructional videos will be developed. Additionally, users will be able upload and send videos of themselves exercising for feedback and assessment. This version will contain bone health educational content, mindfulness and nutrition resources. Receives: Behavioral: Thrivors+BH |
| Thrivors Basic | Experimental | A Thrivors Basic version that lacks customization and video content will be developed. This version will contain bone health educational content, mindfulness and nutrition resources. Receives: Behavioral: Thrivors+BH |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of participants to complete exercise sessions and surveys
Changes in baseline from exercise naive to exercise activated as well as improvements in well-being survey, patient activation measures, and bone health awareness
Measured: 20 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Aug 2018
- Study start21 Jan 2019
- Primary completion1 Mar 2020
- Study completion1 Mar 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 134 participants (actual)
Sponsor and investigators
- Lead sponsor
- Thrivors Inc
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Oregon Health and Science University, Masonic Cancer Center, University of Minnesota, National Cancer Institute (NCI)
- Responsible party
- Principal investigator, Cathy Skinner, Thrivors Inc
- Investigators
- Cathy Skinner, MA, Principal investigator, Thrivors Inc
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03651037
- Sponsor's protocol ID
- THRIVORSBH-01
- Other IDs
- R43CA224412
- Acronym
- THRIVORS+BH
- Status last verified
- Aug 2020
- First submitted
- 27 Aug 2018
- Last updated
- 1 Sep 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Sep 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Physical Activity Platform to Improve Bone Health in Cancer Survivors
- ClinicalTrials.gov ID
- NCT03651037
- Acronym / sponsor ID
- THRIVORS+BH / THRIVORSBH-01
- Conditions
- Breast Cancer, Physical Activity, Bone Health
- Keywords
- cancer, bone health, physical activity, technology platfrom
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 134 participants (actual)
- Lead sponsor
- Thrivors IncIndustry (pharma, biotech, devices)
- Collaborators
- Oregon Health and Science University, Masonic Cancer Center, University of Minnesota, National Cancer Institute (NCI)
- Study start
- 21 Jan 2019 (actual)
- Primary completion
- 1 Mar 2020 (actual)
- Study completion
- 1 Mar 2020 (actual)
- First posted
- 29 Aug 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cancer treatment-induced bone loss and the subsequent risk of fractures in both men and women impacts not just survivors' quality of life, but is also a significant burden on national health care. Clinical studies have reported that moderate-intensity resistance exercises prevent a decline in bone health in female cancer survivors, and that strength training may reduce complications associated with cancer such as fatigue, muscle wasting, and bone loss. Unfortunately, only a small percentage of women who have had cancer, engage in and adhere to a strength training exercise routine.
The investigators have developed an internet-based application, Thrivors, that guides cancer survivors through exercise routines with light-to-moderate strength training in the home setting, and connects them to survivorship resources. In this Phase I proposal, the investigators will develop and deploy an enhanced version, Thrivors+BH, that disseminates resistance training exercises specifically impacting bone health (BH), integrated with video-based interactive feedback and tracking of adherence to exercise routines.
The goal is to validate Thrivors+BH as a novel tool to bridge the gaps between cancer survivorship, physical activity, value-based care and health care organizations (providers and payers), to positively impact bone health in breast cancer survivors.
Detailed description
Significance: Cancer treatment-induced bone loss and the subsequent risk of fractures in both men and women is a significant burden on national health care. The number of cancer survivors in the United States will reach 18 million by 2022 and by 2025, the projected burden of osteoporosis is $25.3 billion. Cancer patients treated with medications that lower hormone levels face an increased risk of fractures. Clinical studies report that moderate- intensity resistance exercises prevent a decline in bone health in female cancer survivors, and that strength training may reduce complications associated with cancer such as fatigue, muscle wasting, and bone loss. Unfortunately, only a small percentage of female cancer survivors engage in and adhere to a strength training exercise routine. Several factors account for this low level of engagement such as poor awareness of the benefits of exercise, lack of motivation, and the lack of affordable and easily accessible exercise programs designed for cancer survivors. Internet-based self-managed programs of exercises and guidance can potentially address these problems, and can be scaled for broader dissemination.
Innovation: The Thrivors internet-based platform seeks to shift the current paradigm of poor adherence to exercise by providing an affordable and accessible means of improving outcomes for cancer survivors. The proposed product, Thrivors+BH, will be a first-of-its-kind offering of clinically validated bone health exercises that can be customized to a cancer survivor's pain and energy levels, with several novel interactive feedback features. The product will also have supportive modules for connecting with a community of other users, mindfulness training, nutritional advice and a repository of educational information. The Thrivors platform is scalable, device-agnostic, and allows analysis of de-identified usage data. With commercialization potential for healthcare providers and health insurance payers, Thrivors provides a value-based care delivery model focused on outcomes. There are multiple important physiologic and psychosocial secondary conditions that could be positively impacted by the Thrivors platform. For this specific application, the investigators will focus on adherence to bone health exercises.
Hypothesis: The investigators hypothesized that breast cancer survivors' adherence to an exercise regimen for bone health can be improved by enhancing the interactive and customizable features of a cloud-based, device-agnostic delivery method. To test the hypothesis and to establish the technical feasibility of the product, the investigators propose the following specific aims:
Specific Aim 1: Develop an enhanced participant experience platform for bone health-specific exercises.
For Thrivors+BH, a module will be developed for participants to input pain and energy levels, enabling real-time customization of exercise regimens. Modules of clinically validated bone health exercises with instructional videos will be developed. Additionally, participants will be able upload and send videos of themselves exercising for feedback and assessment. A Thrivors Basic version that lacks customization and video content will be developed. Both versions will contain bone health educational content, mindfulness and nutrition resources. Milestones: Over a 2-month period, development, usability testing (assessing content, features, input controls, navigational ease and click-through capabilities) and refinement will be completed, to enable deployment in a randomized clinical trial.
Specific Aim 2: Measure participant adherence and engagement. The two versions of the platform will be deployed in a 20-week, two-arm randomized controlled trial of 50 breast cancer survivors. Adherence to exercise sessions (primary outcome) and platform usage will be measured by platform software, while user engagement (secondary outcomes) will be assessed by surveys. Milestones: Differences between primary and secondary outcomes for the control and intervention groups will be evaluated. Usage statistics, motivational responses and user feedback will be used to further refine platform features and content.
The outcomes of this study will help validate the utility of the Thrivors platform in improving cancer survivors' adherence and engagement to exercise routines that positively impact post-treatment recovery. In the near-term, the findings will inform the design of a 12-month Phase II study to evaluate changes in biomarkers of bone health. In the longer term, the project aligns with the business goal to disseminate the Thrivors platform to a larger population of male and female cancer survivors across ethnic/racial minority groups, rural populations, and low socioeconomic status groups. The project also aligns with the mission of the NCI to develop innovative technology and service delivery models that increase the adoption, uptake, and sustainability of evidence-based interventions to improve public health.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Thrivors+BH | Experimental | Behavioral: Thrivors+BHFor Thrivors+BH, a module will be developed for users to input pain and energy levels, enabling real-time customization of exercise regimens. Modules of clinically validated bone health exercises with instructional videos will be developed. Additionally, users will be able upload and send videos of themselves exercising for feedback and assessment. This version will contain bone health educational content, mindfulness and nutrition resources. |
| Thrivors Basic | Experimental | Behavioral: Thrivors+BHA Thrivors Basic version that lacks customization and video content will be developed. This version will contain bone health educational content, mindfulness and nutrition resources. |
Who may qualify
- Ages
- 40 to 70 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Female participants diagnosed at 40 - 70 years with non-metastatic breast cancer.
- Able to provide written informed consent.
- Completed chemotherapy, undergoing adjuvant hormonal therapy.
- Not currently on a prescribed exercise plan and cleared for exercise by physician.
- Access to a smart phone (with a data plan), tablet, or computer (with internet access).
Key exclusion criteria (7 listed)
- Less than 4 weeks post-surgery.
- Diagnosis of osteoporosis.
- Currently participating in two or more 30-min. sessions/week of resistance or impact exercises.
- Specific condition(s) or diagnosis, both physical or psychological, or physical exam finding that precludes participation in a physical exercise program.
- Participant has hemodynamically significant heart disease (e.g., heart failure) or an arrhythmic heart condition requiring medical therapy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Thrivors+BHAlso: ThrivorsDigital health platform for breast cancer patients that measures adherence and engagement. | Behavioural | Thrivors Basic, Thrivors+BH |
Primary outcome
Number of participants to complete exercise sessions and surveys
Time frame: 20 weeks
Changes in baseline from exercise naive to exercise activated as well as improvements in well-being survey, patient activation measures, and bone health awareness
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Sep 2020.
- Individual participant dataSharing planned: No
Related trials for Breast Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Cathy Skinner, MA principal investigator
Thrivors Inc
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Thrivors+BH in people with Breast Cancer and Physical Activity, run by Thrivors Inc at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of participants to complete exercise sessions and surveys (time frame: 20 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2020.